Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial: Docetaxel, Irinotecan, and Carboplatin in the Treatment of Extensive Stage Small Cell Lung Carcinoma

NCT00264134 is registered in ClinicalTrials.gov with Kentuckiana Cancer Institute as lead sponsor.

NCT NCT00264134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00264134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial: Docetaxel, Irinotecan, and Carboplatin in the Treatment of Extensive Stage Small Cell Lung Carcinoma
Lead sponsor
Kentuckiana Cancer Institute
Phase
Phase 1/2
Overall status
Terminated
Start date
June 30, 2003
Completion date
October 31, 2005
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage unresectable, non-small cell lung cancer